• The outcomes of interest were CVD clinical events (all-cause mortality, cardiovascular mortality, non-fatal end points) and CVD risk factors (changes in blood pressure, changes in blood lipids, occurrence of type 2 diabetes). (uea.ac.uk)
  • Primary outcomes comparing pre- and post-, and operational data will be analyzed descriptively and "impact" of the intervention will be calculated using double-difference methods. (biomedcentral.com)
  • Six randomized, controlled trials that compared aspirin and placebo (or no aspirin) in a prospective manner in patients with diabetes who were free of cardiovascular disease at baseline, and in which outcomes for major cardiovascular events or mortality was reported, were included in the analysis. (medicaleconomics.com)
  • One is a cardiovascular outcomes trial called PREVAIL . (medscape.com)
  • NCT03626662 ), the primary outcome was safety and tolerability, and the secondary outcomes were the change in Lp(a) concentrations and olpasiran pharmacokinetic parameters. (nature.com)
  • Community pharmacists present an opportunity for improved management of cardiovascular diseases and health outcomes. (biomedcentral.com)
  • The modifiable behavioral and physiological risk factors can be measured and identified early at primary healthcare (PHC) facilities for early management and improved outcomes. (biomedcentral.com)
  • Outcomes included a major adverse cardiovascular event (MACE), cardiovascular death, myocardial infarction, stroke, and major bleeding (intracranial hemorrhage and major gastrointestinal bleeding). (herts.ac.uk)
  • Outcomes included a major adverse cardiovascular event (MACE), cardiovascular death, myocardial infarction, stroke, and major bleeding (intracranial hemorrhage and major gastrointestinal bleeding).ResultsTwo RCTs included 17,003 East Asians, and 9 RCTs had 117,467 Western participants. (herts.ac.uk)
  • School-based systems change for obesity prevention in adolescents: outcomes of the Australian Capital Territory 'It's Your Move! (edu.au)
  • In addition, the associations of cardiovascular disease with adverse asthma outcomes and asthma control among adults with work-related asthma were examined. (cdc.gov)
  • Cardiovascular disease (CVD) is a leading cause of mortality. (bmj.com)
  • Cardiovascular (CV) diseases are the leading cause of morbidity and mortality in diabetic patients. (hindawi.com)
  • Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of mortality in the United States despite a strong emphasis on prevention, accounting for more than 800,000 deaths in 2017. (jabfm.org)
  • Cardiovascular diseases are a leading cause of mortality globally. (biomedcentral.com)
  • Globally, the risk of premature death from any of the four main noncommunicable diseases for people between the ages of 30 and 70 years declined by 17% between 2000 and 2015,2 mainly owing to reductions in cardiovascular and chronic respiratory disease mortality. (who.int)
  • These findings support the high prothromboticmilieu and the need for further research to determine the effect of antiplatelet/antithrombotictherapy on cardiovascular morbidity and mortality in COPD patients. (ncl.ac.uk)
  • Although men have a greater risk of mortality from CVD, women have a higher mortality from cardiovascular events, such as stroke. (pharmacytimes.com)
  • Although the evidence points to a reduction in cardiovascular events when statins are used for primary prevention, the absolute risk reduction is often small and the studies have not shown a reduction in all-cause mortality. (medscape.com)
  • However, workers with high physical work demands (often low and semi-skilled workers) are well known to have an elevated incidence of cardiovascular disease and premature mortality. (cdc.gov)
  • Recent studies have surprisingly found instead that high physical activity at work actually increases the risk for cardiovascular disease and mortality. (cdc.gov)
  • One possible explanation could involve cardiorespiratory fitness, which is a strong predictor of cardiovascular disease and mortality. (cdc.gov)
  • Subjects Patients aged 30-84 years who were free of cardiovascular disease and not taking statins between 1 January 1994 and 30 April 2010: 2 343 759 in the derivation dataset, and 1 267 159 in the validation dataset. (bmj.com)
  • We therefore aimed to investigate the adoption of adequate risk factor control and its determinants in the general population free of cardiovascular disease (CVD). (uni-wuerzburg.de)
  • The appropriateness of the use of statins for the secondary and primary prevention of atherosclerotic cardiovascular disease: a cross-sectional study from Jordan. (physiciansweekly.com)
  • Patients with inflammatory arthritis (IA) are at high risk for atherosclerotic cardiovascular disease (ASCVD), yet management of dyslipidemia is infrequently prioritized. (bvsalud.org)
  • This book is the first comprehensive text dedicated to risk assessment in the primary prevention of atherosclerotic cardiovascular disease. (icebe.es)
  • The basis for this lack of recognition and less aggressive management of cardiovascular risk in women has largely been a result of the misperception by women and physicians that women are at an inherently low risk for developing heart disease. (aafp.org)
  • Currently, Mary is involved in the screening, prevention and management of cardiovascular disease in primary care. (edu.au)
  • Purpose: The American diabetes association (ADA) standards of medical care in diabetes 2017 recommends considering aspirin therapy as a primary prevention strategy for patients with type 2 diabetes who are at increased cardiovascular risk. (diabetesjournals.org)
  • The aim of this study was to investigate the prescription rate of antiplatelet as a primary prevention treatment in diabetes patients in Taiwan. (diabetesjournals.org)
  • We stratified these patients into three risk group (low, intermediate, and high risk) according to the standards of medical care in diabetes 2017 to explore the utilization of antiplatelet agent as a primary prevention strategy in each risk stratification. (diabetesjournals.org)
  • Conclusions: Aspirin or alternative effective antiplatelet agents as a primary prevention treatment for type 2 diabetes patients with increased cardiovascular risks were underutilized in Taiwan. (diabetesjournals.org)
  • Aspirin's efficacy in preventing first cardiovascular events in patients with diabetes is equivocal, according to a new meta-analysis of prospective, randomized clinical trials. (medicaleconomics.com)
  • As such, better stratification of those patients with diabetes who may benefit from aspirin as primary prevention is needed, he says. (medicaleconomics.com)
  • Various guidelines for the primary prevention of cardiovascular disease in patients with diabetes are inconsistent in their recommendations for the use of aspirin. (medicaleconomics.com)
  • For example, the American Heart Association/American Diabetes Association guidelines recommend its use in all patients with diabetes older than 40 years who have cardiovascular risk factors, whereas the European Society of Cardiology recommends it in diabetics only for stroke prevention, and the Canadian Diabetes Association states that no evidence exists for aspirin use for primary prevention in diabetes and that its use should be left to individual clinical judgment. (medicaleconomics.com)
  • In weighing the overall merit of aspirin use for primary prevention in patients with diabetes, Dr. Nicolucci calculated that 1,000 patients would need to be treated for 1 year to prevent 1 to 2 events. (medicaleconomics.com)
  • Although, currently, treatment has proven useful in reducing vascular events, diabetic patients continue to have a higher risk of adverse cardiovascular events compared with those in nondiabetic patients. (hindawi.com)
  • We applied Canadian dyslipidemia guidelines to determine how many patients with IA would be eligible for primary prevention with statins . (bvsalud.org)
  • The volume seeks to provide an essential resource for professionals in the field to assess their patients for risk of cardiovascular disease. (icebe.es)
  • The systematic review aims to identify the roles of community pharmacists in preventing and controlling cardiovascular diseases and patients' perceptions towards such functions. (biomedcentral.com)
  • The team searched MEDLINE, CINAHL via EBSCOhost, and Web of Science from January 2001 to December 2021 with a focus on studies reporting the role of community pharmacists in preventing and controlling cardiovascular diseases, and patients' perceptions of such roles. (biomedcentral.com)
  • A total of 11 (24%) studies reported patients' perceptions of community pharmacists' contribution in preventing (73%, n = 8) and controlling (27%, n = 3) cardiovascular diseases. (biomedcentral.com)
  • 1 National policies now support targeting of interventions to reduce risk of cardiovascular disease among high risk patients. (bmj.com)
  • In these updated guidelines, the USPSTF recommends that clinicians assess a patient's risk of having a cardiovascular event (like a heart attack or stroke) to decide which patients should be treated with statin therapy. (medicalnewstoday.com)
  • In the same week, a model was presented at the European Society of Cardiology Congress 2022 which echoed the findings of the review, supporting the use of statins in patients over 40 with high cardiovascular disease risk. (medicalnewstoday.com)
  • Emerson Cardiovascular Associates provides comprehensive care, including most of the tests that our patients require. (emersonhospital.org)
  • The primary outcome was blood pressure control among patients with hypertension, in addition to several secondary process indicators along the care pathway. (ubc.ca)
  • The APPLE COPD-ICON2 trial is a prospective 2×2 factorial, double-blinded proof-of-conceptrandomised controlled trial targeting patients with chronic obstructive pulmonary disease (COPD) without priorhistory of cardiovascular disease. (ncl.ac.uk)
  • The primary goal of this trial is to investigate if treatment with antiplatelet therapywill produce the predefined cut-off of platelet inhibition measured using the Multiplate test in COPD patients.Eligible patients were randomised to aspirin plus placebo, ticagrelor plus placebo, aspirin plus ticagreloror placebo only for 6 months. (ncl.ac.uk)
  • The perprotocolADP test response rate to ticagrelaor was 68.8% (95% CI 50.4-82.6%).Platelet response to antiplatelet therapy with aspirin and ticagrelor was not observed in nearly one-thirdof COPD patients without prior history of cardiovascular disease. (ncl.ac.uk)
  • This research includes a range of research methodolgies to implement quality improvement in primary care and uniquely blends Plan-Do-Study-Act cycles with co-design involving patients and health professionals. (edu.au)
  • Statins have been found to moderately benefit patients with cardiovascular disease risk factors, but researchers found socioeconomic disparities among those treated with statins. (pharmacytimes.com)
  • This publication is designed to help the primary care practitioner in the day-to-day management of patients with diabetes. (cdc.gov)
  • This educational case study document is one in a series Other ATSDR of self-instructional modules designed to increase the Case Studies primary health care provider's knowledge of hazardous in substances in the environment and to promote medical Environmental practices that aid in the prevention, evaluation and care Medicine of potentially exposed patients. (cdc.gov)
  • 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (acc.org)
  • 2 For example, in the 2016 European Society of Cardiology (ESC) guideline on CVD prevention, aspirin was not recommended for primary prevention. (bmj.com)
  • A 2018 National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summary (which is not a formal NICE guideline) also reported that the available evidence does not support routinely prescribing aspirin for primary prevention of CVD. (bmj.com)
  • 1. The burden of cardiovascular diseases (CVDs) is increasing rapidly in Africa and this group of diseases is now becoming a public health problem throughout the WHO African Region. (who.int)
  • The first set of risk factors for CVDs, which include family or personal history of cardiovascular disease, race ,2 gender 3 and age ,4 are not modifiable by interventions. (who.int)
  • Cardiovascular diseases (CVDs) are an umbrella term used to describe disorders of the heart and blood vessels such as coronary heart disease, cerebrovascular diseases, peripheral arterial diseases, rheumatic heart disease, congenital heart disease, deep vein thrombosis, and pulmonary embolism [ 1 ]. (biomedcentral.com)
  • As early and effective antiretroviral therapy has become more widespread, HIV has transitioned from a progressive, fatal disease to a chronic, manageable disease marked by elevated risk of chronic comorbid diseases, including cardiovascular diseases (CVDs). (natap.org)
  • abstract = "BackgroundEast Asians have shown different risk profiles for both thrombophilia and bleeding than Western counterparts.ObjectivesThe authors sought to evaluate the effect of low-dose aspirin for primary prevention between these populations.MethodsWe searched randomized clinical trials (RCTs) for intervention with low-dose aspirin (≤100 mg once daily) in participants without symptomatic cardiovascular disease until December 31, 2021. (herts.ac.uk)
  • This statement updates the recommendations of the American Academy abstract of Pediatrics for the routine use of influenza vaccine and antiviral medications in the prevention and treatment of influenza in children during the 2023-2024 influenza season. (cdc.gov)
  • Assessment of ASCVD risk is the foundation of primary prevention. (acc.org)
  • These recommendations were based on numerous studies showing that statins are effective in reducing low-density lipoprotein cholesterol levels, and the risk of death and recurrent coronary and cardiovascular events in those with a history of ASCVD, even in older adults. (jabfm.org)
  • Primary prevention to reduce the risk of ASCVD is an important goal for PLWH. (natap.org)
  • Pursuant to the request in resolution WHA70.11 (2017) the Director-General submits this report on preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018, for consideration of the Executive Board and then the Seventy-first World Health Assembly in May 2018. (who.int)
  • The prevalence of hypertension and other cardiovascular risk factors are described for participants with and without a history of cardiovascular disease (CVD). (nih.gov)
  • Of 3534 subjects, more than one-third (n = 1230, 35.2%) have a history of cardiovascular disease. (nih.gov)
  • Statin use would yield moderate benefit for those ages 40-75 with one or more factors that could increase the risk of cardiovascular disease, no history of cardiovascular disease, and an estimated 10-year cardiovascular event risk of 10% or greater. (medicalnewstoday.com)
  • The aim of this paper is to provide summative evidence of some of the known effective interventions that may reduce cardiovascular risk in people living with SMI. (racgp.org.au)
  • 12 The PRIMROSE study, a UK cluster RCT of proactive nurse-delivered interventions in general practice to reduce cardiovascular risk, 6 observed a reduction in total cholesterol over 12 months in both the intervention and control groups. (racgp.org.au)
  • Ongoing randomized, controlled trials will help clarify whether aspirin confers additional benefits on top of current strategies to reduce cardiovascular risk. (medicaleconomics.com)
  • This is because age has such a dominant effect in calculating absolute cardiovascular risk. (bmj.com)
  • There is a need for larger well conducted RCTs assessing cardiovascular events as well as cardiovascular risk factors. (uea.ac.uk)
  • The findings highlight community pharmacists' capability of providing primary healthcare services in preventing and controlling cardiovascular diseases and provide evidence for their inclusion in primary healthcare frameworks. (biomedcentral.com)
  • Methods: The objective of this cross-sectional study was to assess the association between work-related asthma status and cardiovascular disease among ever-employed adults (aged 18-64 years) with current asthma using data from the 2012-2017 Behavioral Risk Factor Surveillance System Asthma Call-Back Survey from 37 states and the District of Columbia. (cdc.gov)
  • Methods: Data from the Characteristics and Course of Heart Failure Stages A-B and Determinants of Progression (STAAB) Cohort Study, a population-based study of inhabitants aged 30 to 79 years from the Background: While data from primary care suggest an insufficient control of vascular risk factors, little is known about vascular risk factor control in the general population. (uni-wuerzburg.de)
  • Atlanta, Georgia: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division for Heart Disease and Stroke Prevention, 2022. (cdc.gov)
  • Centers for Disease Control and Prevention. (cdc.gov)
  • The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. (cdc.gov)
  • Large clinical trials have shown that antiplatelet agents are effective in the prevention of recurrent cardiovascular events in diabetes. (hindawi.com)
  • 5 Antipsychotic medications are associated with a range of cardiovascular and metabolic abnormalities, such as obesity, hyperglycaemia, dyslipidaemia, and an increased risk of type 2 diabetes mellitus and CVD. (racgp.org.au)
  • The burden of cardiovascular disease is rising in sub-Saharan Africa with hypertension being the main risk factor. (biomedcentral.com)
  • Platelets have a "key role" in atherogenesis and its thrombotic complications in subjects with DM [ 3 ], and the concomitant presence of multiple "classical" cardiovascular risk factors (arterial hypertension, cigarette smoking, and hyperlipidemia) in diabetic subjects contributes to enhanced atherothrombotic risk. (hindawi.com)
  • There is little information on the prevalence of hypertension and other modifiable cardiovascular risk factors in community-dwelling elderly in the Netherlands and the potential impact of improving antihypertensive treatment on major cardiovascular events. (nih.gov)
  • Hypertension and other cardiovascular risk factors are very common in elderly subjects. (nih.gov)
  • hypertension, smoking, obesity, physical inactivity, unhealthy diet, high cholesterol, excessive alcohol consumption and diabetes .5,6 These risk factors are amenable to prevention or control through the adoption of appropriate health policies by governments which encourage the adoption of healthy lifestyles by individuals. (who.int)
  • Background: The aim of this study was to determine the feasibility of implementing and evaluating essential interventions for the management of hypertension and prevention of cardiovascular disease in primary healthcare in Tajikistan. (ubc.ca)
  • Omega 6 plays a vital role in many physiological functions but there is controversy concerning its effect on cardiovascular disease (CVD) risk. (uea.ac.uk)
  • These studies indicate that high physical activity during work may impose a qualitatively different effect on cardiovascular health than high physical activity during leisure time. (cdc.gov)
  • 4 This publication further states that aspirin is not licensed for primary CVD prevention, aspirin is associated with harm and that adults can reduce their CVD risk by other means such as smoking cessation and statin therapy. (bmj.com)
  • Two analytical studies were undertaken using longitudinal data from The Health Improvement Network (THIN) primary care database to investigate: 1) CVD screening and statin prescribing in people with and without SMI and 2) to explore the effectiveness of statins for CVD prevention in individuals with SMI. (ucl.ac.uk)
  • Statin Use for Primary Cardiovascular Disease Prevention Is Low in Inflammatory Arthritis. (bvsalud.org)
  • The U.S. Preventive Services Task Force (USPSTF) recently published its Recommendation Statement for Statin Use for the Primary Prevention of Cardiovascular Disease in Adults in the Journal of the American Medical Association (JAMA). (medicalnewstoday.com)
  • Cholesterol guidelines typically prioritize primary prevention statin therapy based on 10-year risk of cardiovascular disease. (ox.ac.uk)
  • This recommendation replaces the 2016 USPSTF recommendation on statin use for the primary prevention of CVD and is generally consistent with that recommendation," the USPSTF stated in a guidance published in JAMA . (pharmacytimes.com)
  • Statin Use for the Primary Prevention of Cardiovascular Disease in Adults. (pharmacytimes.com)
  • The primary event rate was 8.1% without a statin and 6.3% with a statin, an absolute risk reduction with a statin of 1.8% (P = .13). (medscape.com)
  • The prevalence and burden of cardiovascular disease (CVD) is high, and it remains the leading cause of death worldwide. (nih.gov)
  • Cardiovascular disease (CVD) remains the most common cause of death in women and men in the developed world, despite the multiple epidemiologic and interventional studies that demonstrate significant declines in CVD incidence and prevalence with adherence to a healthy lifestyle and identification and treatment of risk factors. (aafp.org)
  • The intervention community (Korogocho) will be exposed to an intervention package for primary prevention of cardiovascular disease that comprises awareness campaigns, household screening for cardiovascular diseases risk factors, and referral and treatment of people with high cardiovascular diseases risk at a primary health clinic. (biomedcentral.com)
  • Lead author Dr. Runguo Wu of the Queen Mary University of London said: "Our study suggests that people who start taking statins in their 50s but stop at 80 years of age instead of continuing lifelong will lose 73% of the QALY benefit if they are at relatively low cardiovascular risk and 36% if they are at high cardiovascular risk - since those at elevated risk start to benefit earlier. (medicalnewstoday.com)
  • (http://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html, accessed 27 November 2017). (who.int)
  • In addition to accounting for the presence or absence of preexisting coronary heart disease or its equivalents (e.g., diabetes, chronic kidney disease), cardiovascular risk can be further calculated with the Framingham risk score, which is based on age, sex, smoking history, and lipid and blood pressure levels. (aafp.org)
  • Although bacteria play a role in all forms of gingivitis, the primary cause of chronic gingivitis is inadequate oral hygiene. (medscape.com)
  • Will adopting a specific food pattern prevent major chronic diseases such as type 2 diabetes, cardiovascular disease, or cancer? (bmj.com)
  • Cardiovascular disease is the leading cause of premature death and a major cause of disability in the UK. (bmj.com)
  • Cardiovascular disease is also a leading cause of premature death, causing 38% of deaths before age 70. (medicalnewstoday.com)
  • Cardiovascular disease (CVD), largely driven by the combined effect of several modifiable risk factors such as smoking and obesity, is the leading contributor accounting for one-fifth of the health gap ( 1 ). (frontiersin.org)
  • Lifestyle interventions are important for preventing cardiovascular disease, with smoking, obesity, diabetes, lack of physical exercise, and excessive consumption of alcohol all increasing the risk of developing cardiovascular disease. (medicalnewstoday.com)
  • She has extensive project management, data collection, data management and statistical analysis experience from community and systems based obesity prevention interventions in children and adolescents. (edu.au)
  • Outcome results for the Ma'alahi Youth Project, a Tongan community-based obesity prevention programme for adolescents. (edu.au)
  • Around one-fifth of the health disparity is caused by cardiovascular disease (CVD). (frontiersin.org)
  • Given our knowledge of what can only be referred to as a cardiovascular health crisis for people living with severe mental illness (SMI), we propose that the old problem of the 'elephant in the room' has reared its head. (racgp.org.au)
  • Two recently completed randomised controlled trials (RCTs) emphasise an important role for primary care in tackling this major health problem. (racgp.org.au)
  • Since 2008, 16 systematic reviews have focused on the impact of pharmacological and non-pharmacological interventions on different aspects of cardiovascular health, CVD risk factors and/or other related physical health problems specifically for people living with SMI. (racgp.org.au)
  • The data sources listed here provide a wide variety of cardiovascular health-related information. (cdc.gov)
  • An attempt was made to include most cardiovascular health-related data sources in this guide. (cdc.gov)
  • The fourth section offers insight on novel risk factors, with in-depth discussion regarding lipoprotein(a), high-sensitivity CRP, apolipoprotein B, social determinants of health, stress and cardiovascular disease. (icebe.es)
  • According to the World Health Report 2001, cardiovascular diseases accounted for 9.2% of the total deaths in the Region in 2000 (more than the deaths caused by malaria) as compared with 8.15% in 1990. (who.int)
  • However, these factors are either already taken care of through other initiatives or programmes (reproductive health, HIV/AIDS prevention and control), need more research or are not amenable to cost-effective preventive interventions. (who.int)
  • In addition, new guidelines were necessitated by the publication of results from several large CVD prevention trials, most notably the Women's Health Initiative trial, which confirmed the lack of cardiovascular protection afforded by estrogen use in women after menopause. (aafp.org)
  • (http://www.who.int/gho/publications/world_health_statistics/2017/en/, accessed 27 November 2017). (who.int)
  • We have special training in diagnosing and treating the full range of conditions, and we emphasize prevention strategies designed to keep you in the best possible health. (emersonhospital.org)
  • Jonathan Greene, MD, discusses why cholesterol is such a core component in cardiovascular health. (emersonhospital.org)
  • All primary health care facilities that met inclusion criteria in Shahrinav district were included and computer randomized to either usual care or intervention. (ubc.ca)
  • Results: 19 primary health care centres were included of which ten were randomized to intervention and nine to control. (ubc.ca)
  • Conclusions: It is feasible to use routine, paper-based, clinical records to evaluate essential CVD interventions in primary health care in Tajikistan. (ubc.ca)
  • Primary prevention, early diagnosis, and implementation of optimal work-related asthma management are essential for workers' health. (cdc.gov)
  • Occupational and leisure time physical activity: do they have similar effects on cardiovascular health? (cdc.gov)
  • Statins certainly have been shown time and again to reduce the incidence of cardiovascular events, but there is a bigger picture-a broader perspective-that often gets bumped aside in our focus on evidence-based medicine. (medscape.com)
  • After completing a cardiology fellowship, Michael spent two additional years in a clinical and research fellowship focused on advanced cardiovascular imaging at Massachusetts General Hospital/Harvard Medical School. (icebe.es)
  • Cardiovascular disease among adults with work-related asthma, 2012-2017. (cdc.gov)
  • BMC Cardiovascular Disorders (2017) 17:276. (uni-wuerzburg.de)
  • 1 , 3 , 4 , 5 However, there has been some uncertainty about the place of aspirin for the primary prevention of cardiovascular events. (bmj.com)
  • Available antiplatelet agents, such as cyclooxygenase-1 (COX-1) inhibitors (aspirin), ADP P2Y 12 receptor antagonists, and GP IIb/IIIa receptor inhibitors, are effective and save in the treatment and prevention of thrombotic events, these drugs interfere with the platelet activation process, including adhesion, release, and aggregation. (hindawi.com)
  • A Path to Primary Prevention of Coronary Artery Disease: Can We All Live to 100? (stanford.edu)
  • citation needed] Coronary artery disease (also known as coronary heart disease and ischemic heart disease) Peripheral arterial disease - disease of blood vessels that supply blood to the arms and legs Cerebrovascular disease - disease of blood vessels that supply blood to the brain (includes stroke) Renal artery stenosis Aortic aneurysm There are also many cardiovascular diseases that involve the heart. (wikipedia.org)
  • Pharmacological and non-pharmacological interventions are available and can be used in primary care for CVD risk reduction in people with SMI. (racgp.org.au)
  • The 1982 publication of The Prevention and Treatment of Five Complications of Diabetes: A Guide for Primary Care Practitioners was an initial attempt to provide straightforward and practical information that primary care practitioners could immediately apply in their practice in the diagnosis and prevention of complications of diabetes. (cdc.gov)
  • [3] Most cardiovascular disease affects older adults. (wikipedia.org)
  • Introduction: Asthma is associated with an increased risk for cardiovascular disease, and adults with persistent, severe asthma have a significantly higher risk of cardiovascular disease than adults with intermittent or no asthma. (cdc.gov)
  • 95% CI=1.0, 1.5) were significantly more likely to have cardiovascular disease than adults with non-work-related asthma. (cdc.gov)
  • Cardiovascular disease should be considered where appropriate when diagnosing and recommending treatment and interventions for adults with work-related asthma. (cdc.gov)
  • Primary prevention of lead exposure is the most important and significant strategy to protect children and adults from lead exposures. (cdc.gov)
  • The researchers concluded from these findings that statins would offer no benefit in the primary prevention of cardiovascular disease (CVD) in adults over age 65. (medscape.com)
  • Cardiovascular disease (CVD) is the leading cause of death amongst people with severe mental illness (SMI) and drives substantial portion of the 15-20 year deficit in life expectancy experienced by this group relative to the general population. (ucl.ac.uk)
  • Cardiovascular diseases are the leading cause of death worldwide except Africa. (wikipedia.org)
  • Cardiovascular disease (CVD) remains the leading cause of death in the United States. (cdc.gov)
  • Cardiovascular disease is the leading cause of death and disability globally, and there have been concerted efforts for decades to prevent and minimize its impact. (medicalnewstoday.com)
  • Overall, 63% of subjects have two or more cardiovascular risk factors amenable to treatment. (nih.gov)
  • We searched randomized clinical trials (RCTs) for intervention with low-dose aspirin (≤100 mg once daily) in participants without symptomatic cardiovascular disease until December 31, 2021. (herts.ac.uk)
  • Surveillance and Evaluation Data Resource Guide for Heart Disease and Stroke Prevention Programs. (cdc.gov)
  • Surveillance and Evaluation Data Resources for Heart Disease and Stroke Prevention Programs is an at-a-glance compilation of data sources useful for heart disease and stroke prevention programs conducting policy or data surveillance and/or evaluation. (cdc.gov)
  • This guide addresses the broad spectrum of programs supported by the Division for Heart Disease and Stroke Prevention, and not all sources are applicable to all programs. (cdc.gov)
  • It is meant to be used by program managers and evaluators in the planning and evaluation stages of heart disease and stroke prevention programs. (cdc.gov)
  • Our objective is to provide basic information on each data source to assist state heart disease and stroke prevention programs in identifying data that are relevant to planning, monitoring, and evaluation. (cdc.gov)